Biohaven Pharma (BHVN) Earnings
|
Expand Research on BHVN
| Next EPS Date | 11/17/26 | EPS Growth Rate | +53.7% |
|---|---|---|---|
| Average EPS % Beat Rate | +6.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -6.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/17/26  |
Q326 | N/A | -$0.76 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/10/26 |
Q226 | -$0.78 | -$0.75 | -$0.03 | N/A | N/A | N/A |  | | Details | |
| 5/4/26 |
Q126 | -$0.88 | -$0.84 | -$0.04 | N/A | $294.18K | N/A | | | Details | |
| 3/2/26 |
Q425 | -$0.90 | -$1.18 | +$0.28 | N/A | N/A | N/A | | | Details | |
| 11/10/25 |
Q325 | -$1.64 | -$1.88 | +$0.24 | N/A | $412.57K | N/A | | | Details | |
| 8/11/25 | Q225 | -$1.63 | -$1.94 | +$0.31 | N/A | N/A | N/A | | | Details | |
| 8/6/25 |
Q225 | N/A | -$1.94 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/4/25 |
Q225 | N/A | -$1.94 | N/A | N/A | N/A | N/A | N/A | N/A |
